Impact of hospitalized vaso-occlusive crises in the previous calendar year on mortality and complications in adults with sickle cell disease: a French population-based study

Arlet, Jean-Benoît; Herquelot, Eléonore; Lamarsalle, Ludovic; Raguideau, Fanny; Bartolucci, Pablo

doi:10.1016/j.lanepe.2024.100901

The Lancet Regional Health - Europe

2024

DOI: 10.1016/j.lanepe.2024.100901

|View full text |Cite

Impact of hospitalized vaso-occlusive crises in the previous calendar year on mortality and complications in adults with sickle cell disease: a French population-based study

Jean-Benoît Arlet,

Eléonore Herquelot,

Ludovic Lamarsalle

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 20 publications

(22 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID‐19 pandemic: A multicentre cohort study

Rech,

Cohen,

Bartolucci

et al. 2024

Br J Haematol

View full text Add to dashboard Cite

SummaryWhile the coronavirus disease‐2019 (COVID‐19) might have increased acute episodes in people living with sickle cell disease (SCD), it may also have changed their reliance on emergency department (ED) services. We assessed the impact of the COVID‐19 pandemic and lockdowns on ED visits in adult SCD people followed in five French reference centres, with a special focus on ‘high users’ (≥10 visits in 2019). We analysed the rate of ED visits from 1 January 2015 to 31 December 2021, using a self‐controlled case series. Among 1530 people (17 829 ED visits), we observed a significant reduction in ED visits during and after lockdowns, but the effect vanished over time. Compared to pre‐pandemic, incidence rate ratios for ED visits were 0.59 [95% CI 0.52–0.67] for the first lockdown, 0.66 [95% CI 0.58–0.75] for the second and 0.85 [95% CI 0.73–0.99] for the third. High users (4% of people but 33.7% of visits) mainly drove the reductions after the first lockdown. COVID‐19 lockdowns were associated with reduced ED visits. While most people returned to their baseline utilization by April 2021, high users had a lasting decrease in ED visits. Understanding the factors driving the drop in ED utilization among high users might inform clinical practice and health policy.

show abstract

Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID‐19 pandemic: A multicentre cohort study

Rech,

Cohen,

Bartolucci

et al. 2024

Br J Haematol

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Impact of hospitalized vaso-occlusive crises in the previous calendar year on mortality and complications in adults with sickle cell disease: a French population-based study

Cited by 1 publication

References 20 publications

Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID‐19 pandemic: A multicentre cohort study

Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID‐19 pandemic: A multicentre cohort study

Contact Info

Product

Resources

About